DAVIS: Looming deadline not so big now
The exact words the doctor used that day are forever lost in a blur of
hospital gowns and ultrasound gel and post-biopsy instructions.
Cancer
Articles
Endocyte, Purdue develop prostate cancer treatment device
Purdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed
a prostate cancer “homing device” to help anti-cancer agents specifically target prostate
cancer tumors.
Cook splits device unit to focus on cancer products
Cook Medical has split its interventional devices business into two units, pulling its lesser known cancer products out from under the shadow of its heart products.
Lilly buys ImClone as part of strategy to capitalize on cancer-drug market
Eli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now
the best-selling class of drugs in the world and one of the fastest growing.